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Abstract
Background and Aims: The Australian National University AD Risk Index (ANU-ADRI, http://anuadri.anu.edu.au) is a self-
report risk index developed using an evidence-based medicine approach to measure risk of Alzheimer’s disease (AD). We
aimed to evaluate the extent to which the ANU-ADRI can predict the risk of AD in older adults and to compare the ANU-
ADRI to the dementia risk index developed from the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study for
middle-aged cohorts.
Methods: This study included three validation cohorts, i.e., the Rush Memory and Aging Study (MAP) (n = 903, age $53
years), the Kungsholmen Project (KP) (n = 905, age $75 years), and the Cardiovascular Health Cognition Study (CVHS)
(n = 2496, age $65 years) that were each followed for dementia. Baseline data were collected on exposure to the 15 risk
factors included in the ANU-ADRI of which MAP had 10, KP had 8 and CVHS had 9. Risk scores and C-statistics were
computed for individual participants for the ANU-ADRI and the CAIDE index.
Results: For the ANU-ADRI using available data, the MAP study c-statistic was 0?637 (95% CI 0?596–0?678), for the KP study it
was 0?740 (0?712–0?768) and for the CVHS it was 0?733 (0?691–0?776) for predicting AD. When a common set of risk and
protective factors were used c-statistics were 0.689 (95% CI 0.650–0.727), 0.666 (0.628–0.704) and 0.734 (0.707–0.761) for
MAP, KP and CVHS respectively. Results for CAIDE ranged from c-statistics of 0.488 (0.427–0.554) to 0.595 (0.565–0.625).
Conclusion: A composite risk score derived from the ANU-ADRI weights including 8–10 risk or protective factors is a valid,
self-report tool to identify those at risk of AD and dementia. The accuracy can be further improved in studies including more
risk factors and younger cohorts with long-term follow-up.
Citation: Anstey KJ, Cherbuin N, Herath PM, Qiu C, Kuller LH, et al. (2014) A Self-Report Risk Index to Predict Occurrence of Dementia in Three Independent
Cohorts of Older Adults: The ANU-ADRI. PLoS ONE 9(1): e86141. doi:10.1371/journal.pone.0086141
Editor: Jialin Charles Zheng, University of Nebraska Medical Center, United States of America
Received June 5, 2013; Accepted December 5, 2013; Published January 23, 2014
Copyright:  2014 Anstey et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Dr C Qiu is supported by the Swedish Research Council, Stockholm, Sweden. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: kaarin.anstey@anu.edu.au
Introduction
Alzheimer’s dementia (AD) affects approximately 35.6 million
people worldwide, and this will increase with population ageing
[1]. There is increasing focus on delaying the onset of AD through
intervening to modify risk factors [2,3], and it has been estimated
that a 10–25% reduction in seven key risk factors could prevent
1?1–3?0 million AD cases internationally [2]. Hence, it is useful to
have scientifically based tools that measure individuals’ risk factor
profiles associated with developing late-life AD.
Development of risk assessment tools poses several challenges in
the field of dementia and more generally. Most often, tools are
developed by analysing a single cohort and identifying a set of
predictors from that individual study using logistic regression and
receiver operating characteristics to identify optimal cut-offs. This
approach has been used in many areas of health and medicine,
such as developing falls risk indices, the Framingham risk score, a
risk index for identifying unsafe drivers, and risk indices for
dementia. The main limitation of this approach is that the risk
index is optimised for the study from which it was derived.
Without external validation, it is not possible to know how
generalizeable such risk indices are. An alternative approach is to
develop a risk index based on synthesis of information about risk
factors derived from multiple cohort studies. To date we know of
few examples of this in the literature. This latter approach requires
that sufficient data have been published relating to individual risk
factors.
Using an Evidence-Based Medicine approach involving data
synthesis we developed the Australian National University AD
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Risk Index (ANU-ADRI) [4], to identify the degree to which
individuals are ‘at-risk’ of AD based on the risk factors identified in
epidemiological studies that could be measured using self-report.
This assessment tool differs from previous tools developed to
predict dementia because it was not developed by identifying risk
factors from a single cohort study and does not include any
variables that require clinical assessment or laboratory tests.
In studies reporting the general outcome of ‘dementia’ as well as
specific subtypes of dementia such as AD, or Vascular Dementia,
results for ‘dementia’ are often similar to that of AD because AD
accounts for up to 75% of all dementia cases. Hence, although we
developed the ANU-ADRI from literature reporting effects for AD
specifically, we evaluate the tool against both diagnoses of AD and
the more general diagnostic outcome of dementia. If it predicts
both outcomes, it will have a wider utility.
The aim of the present study is to evaluate the ANU-ADRI by
estimating the associations between ANU-ADRI and incident AD
and dementia in three cohorts from two countries (USA and
Sweden). Second, we aimed to evaluate whether the ANU-ADRI
had improved capacity to predict AD and dementia compared
with a previously published dementia risk score developed on a
single cohort [5] based on midlife assessments of risk factors. This
would provide information on the utility of that measure used in
older cohorts, and the capacity of the ANU-ADRI to contribute to
the range of available low-cost dementia risk assessment tools.
Methods
The ANU-ADRI
The development of the ANU-ADRI has been previously
described and is summarised here briefly [4]. An Evidence-based
Medicine Approach was used to identify risk and protective factors
for AD that could be measured by self-report. We systematically
searched the literature and identified 11 risk factors (age, sex, low
education, diabetes, traumatic brain injury, depressive symptoms,
smoking, low social networks) and four protective factors
(cognitively stimulating activities, alcohol consumption, physical
activity, fish intake) for AD for which pooled estimates of risk ratios
had been published or could be estimated from high quality
articles meeting criteria used in previous publications [13–16].
The definitions of variables in the ANU-ADRI algorithm were
derived from the exposure variables used in meta-analyses from
which risk ratios were derived, except where this was not possible.
The points for each factor were derived from beta-weights from
converted published odds ratios using the method described
previously [5]. To create an integer level scoring system, scores
were multiplied by a constant. Individual ANU-ADRI scores were
created by an algorithm that sums the points attributed to
individual risk and protective factors using an additive method
[5,17].
For each of the three cohort studies, all predictive variables
included in the ANU-ADRI were selected from their baseline or
from the first occasion at which the risk factor was measured.
Table 1 shows the measures used for each risk and protective
factor in each cohort. They were coded as categorical variables
and assigned a score according to the point system described
above.
We excluded BMI and cholesterol measures because these
factors, when measured in late life (60 years and older), have not
been conclusively associated with increased risk of AD [13,14].
Participants diagnosed with dementia at baseline were excluded
from analysis as were participants who had missing data for
diagnosis of AD or dementia at last follow-up.
Validation samples
We reviewed the literature to identify high quality longitudinal
studies including a large proportion of the risk factors included in
the ANU-ADRI, and longitudinal follow-up for AD and dementia.
No study was identified that included all the risk and protective
factors included in the ANU-ADRI, and that had dementia
diagnoses. Three studies were identified with nine or more risk or
protective factors and were available for analysis by the study
owners.
The Rush Memory and Aging Project (MAP) comprised 1164
participants aged 53 years and older who were initially assessed in
1997 and followed for an average of 3?5 years. The study design
and details of dementia diagnosis have been previously published
[6]. The diagnosis of dementia and AD were established by
experienced physicians using the National Institute of Neurolog-
ical and Communicative Diseases and Stroke–Alzheimer’s Disease
and Related Disorders Association (NINCDS-ADRA) criteria for
diagnosis of AD. For the MAP project, Age, Gender, Education,
Diabetes, Traumatic Brain Injury, Cognitive Stimulating Activi-
ties, Social Engagement, Smoking, Alcohol, Physical Activity were
included in the computation of the ANU-ADRI. The possible
range of the ANU-ADRI scores was 213 to 64. There were 903
participants with complete data used in the analysis of MAP at
baseline.
The Kungsholmen Project (KP) comprised 1301 participants
initially aged 75 years and older who were assessed in 1987–1989
and followed in 1991–1993 and 1994–1996 for an average of 6
years. Details of the design and diagnosis of dementia have also
been published previously [7,8]. The baseline dementia-free
cohort was determined using a two-phase procedure, that is, a
screening phase for all participants (n = 1810) with a structured
interview and the administration of Mini-Mental State Examina-
tion (MMSE), followed by a clinical phase for all those with
MMSE score ,24 and an age- and sex-matched random sample
of those with MMSE score $24. AD and dementia were
diagnosed according to DSM-III-R criteria by physicians using a
validated three-step diagnostic procedure [9]. The algorithm for
the KP included Age, Gender, Education, Diabetes, Traumatic
Brain Injury, Social Engagement, Smoking, Alcohol Consump-
tion. The physical and cognitive activity measures were not
comparable to those included in the ANU-ADRI and hence could
not be included. The potential range of ANU-ADRI scores was 2
3 to 61. A total of 905 participants had complete data on risk
factors and were included in the present study.
The Cardiovascular Health Cognition Study (CVHS) was an
ancillary study of a larger Cardiovascular Health Study which was
initiated in 1989–1990 with 5201 primarily Caucasian adults aged
65 years and older. In the fifth year of the study 687 African
American adults were added [10–12]. The CVHS was initiated in
1998–1999 with 3606 subjects who had a cerebral MRI and
Modified MMSE in 1991–1994. For the present study participants
who had dementia at baseline were excluded so the potential
sample for analysis included 3375 participants followed for an
average of 6 years. Dementia was diagnosed based on a
progressive or static cognitive deficit of sufficient severity to affect
the participant’s activities of daily living in at least two cognitive
domains, which did not necessarily include memory. As previously
described, type of dementia was classified as probable or possible
AD (NINCDS-ADRDA), probable or possible vascular dementia
(State of California Alzheimer’s Disease Diagnostic and Treatment
Centers criteria), mixed dementia, or other dementia. MRI
findings were used only to aid in classification of dementia but
not in the initial dementia diagnosis. All dementia cases were
assessed and confirmed by expert neurologists and psychiatrists.
ANU-ADRI Validation
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The baseline assessment included nine of the fifteen factors in the
ANU-ADRI (Age, Gender, Education, Diabetes, Depressive
symptoms, Smoking, Alcohol, Physical Activity, Fish Intake)
yielding a potential range of the ANU-ADRI scores of 211 to
56. There were 2496 participants with complete data on the ANU-
ADRI.
All three studies received approval from their Institutional
Review Boards. The ANU-ADRI study protocol was approved by
the Human Research Ethics Committee at the Australian National
University, Canberra (protocol number: 2011/064). Datasets are
available from the authors affiliated with each study and the syntax
for this study is available from KJA and MH.
The Cardiovascular Risk Factors, Aging and Dementia
(CAIDE) Index
The CAIDE index was developed through analysis of the
CAIDE cohort study (n= 1409) which is one of the few studies to
measure risk factors in midlife and follow participants until late life
and obtain dementia diagnoses [5]. The CAIDE risk score
included a subset of items included in the ANU-ADRI although
they were defined according to the data available in the CAIDE
baseline assessment. The CAIDE risk index included age (.47
years), sex (female), low education (,10 years), hypercholesterol-
aemia (.6.5 mmol/L), high systolic blood pressure (.140 mm
Hg), physical activity (active versus non-active) and obesity (BMI$
30 kg/m2). A CAIDE equivalent score was calculated for MAP,
KP and CVHS. Weights were applied to each risk factor as
previously reported [5]. A CAIDE score was also calculated by
excluding BMI and BMI and cholesterol because of the older age
of the validation cohorts.
Statistical analyses
The accuracy of the statistical models for identifying partici-
pants at risk of AD using the ANU-ADRI was quantified by
calculating the area under the (AUC), c-statistics, and 95%
confidence interval for each study. The c-statistic integrates the
measures of sensitivity and specificity of the variables included in
the model with a value of 1?00 being associated with perfect
predictive value and a value of 0?50 or less being associated with
chance. The predictive accuracy of the proposed statistical model
was further evaluated for each gender and for the outcome of any
dementia.
The ANU-ADRI score was calculated by adding points
allocated to individual risk/protective factors. The methodology
for the scoring system has been previously published in detail [4].
Protective factors had negative weights indicating their association
with reduced risk of AD or dementia. For each study, the
distribution of ANU-ADRI scores was divided into quartiles within
each study. Cumulative hazards ratios for conversion to AD were
estimated for each quartile using cox regression, and incidence
rates for each quartile of the ANU-ADRI scores were estimated
based on the observed data.
To assess whether results were biased due to missing data within
each dataset, analyses were also run using multiple imputation
Table 1. Risk and protective factors included from each cohort.
Risk/protective factor MAP KP CVHS ANU-ADRI
Age and gender Self report Self report Self report Self report
Education Number of years Number of years Number of years Scale was created using number
of years
Diabetes History of diabetes
and medication
History of diabetes,
medication and blood test
History of diabetes,
medication and blood test
History of diabetes and
medication
Traumatic Brain Injury History for TBI with loss of
consciousness
History for TBI with loss of
consciousness
NA History for TBI with loss of
consciousness
Cognitive activity A structured interview focused on
cognitive activities in late life




5 domains (marital status,
size of social network, quality
of social network, level of social
activities and living arrangements)
5 domains (marital status,
size of social network,
quality of social network,
level of social activities and
living arrangements)
NA 5 domains (marital status, size of
social network, quality of social
network, level of social activities
and living arrangements)
Smoking Questions for smoking statues
(current smoking, ever
smoking and never smoking)
Only asked for current smoking
and never smoking)
Questions for smoking
status (current smoking, ever
smoking and never smoking)
Questions for smoking status
(current smoking, ever smoking
and never smoking)
Alcohol Categories were calculated
according to NHMRC guidelines
using number of drinks per week.
The scale in the variable
included non-alcoholics and
light to moderate alcoholics.
Categories were calculated
according to NHMRC
guidelines using number of
drinks per week.
Categories were calculated
according to NHMRC guidelines
using number of drinks per week.
Physical activity Minnesota Leisure Time Physical
Activity Questionnaire: categories
were calculated using MET






were calculated using MET
Fish intake NA NA Modified National Cancer
Institute FFQ
National Cancer Institute FFQ
Depression symptoms NA NA CES-D (10 item) .11 was
used as cutoff
CES-D (20 item) .16 was used as
cutoff
NHMRC- Australian National Health and Medical Research Council, MET- Metabolic Equivalent, FFQ- Food Frequency Questionnaire, CES-D- Centre for Epidemiology
Scale for Depression. NA=Not available or data not compatible with ANU-ADRI scoring.
doi:10.1371/journal.pone.0086141.t001
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(MI) with 10 datasets using the MI procedure in SPSS which
estimates the pooled effects based on analyses of the imputed
datasets [18]. Results from analyses using the imputed datasets did
not differ significantly from those of the original datasets (data not
shown). Results reported were based on complete cases. To
provide comparison of the accuracy of the ANU-ADRI with an
index derived from a single cohort study, c-statistics were also
calculated for the MAP, KP and CVHS cohorts for the risk index
developed on the CAIDE studies [5].
Results
Description of the three validation samples
Table 2 shows the characteristics of the evaluation cohorts and
the frequency of the individual risk factors within each study
cohort using the categories for each risk factor included in the
ANU-ADRI. MAP was the only study to include participants
classified in the midlife range (aged between 40 and 60) but this
only represented 2% of the total sample. The KP sample was older
than that of the other two studies at baseline. The three samples
differed in the prevalence of several risk factors and in the
inclusion of risk factors measured at baseline. Over 90% of the
MAP participants reported having more than 11 years of
education. The KP cohort included a large proportion of
participants with fewer than eight years of education, The
proportions of incident dementia cases occurring during the
follow-up periods were highest in the MAP and KP cohorts; the
proportions of incident AD were 17?5% for MAP, 20?0% for KP
and 11?1% for CVHS. The points attributed to each of the risk
and protective factors are also reported in Table 2.
Results of predictive analyses in each cohort
Table 3 reports the results of the analyses evaluating the
accuracy of the ANU-ADRI for predicting AD and dementia in
each cohort. C-statistics for the ANU-ADRI predicting AD were
0?733 (95% CI 0?691–0?776) for the MAP study, 0?637 (95% CI
0?596–0?678) for the KP study, and 0?740 (95% CI 0?712–0?768)
for the CVHS study. The number of risk/protective factors
included for each study was 10, 8 and 9 for MAP, KP and CVHS
respectively. The ANU-ADRI risk score quartiles for individual
studies with their median values are also presented in Table 4. The
higher scores for each quartile of the KP study reflect the older age
of this cohort. When only common variables among studies were
included in analyses (age, sex, education, diabetes, smoking and
alcohol) the c-statistics were 0.734 (95% CI 0.707–0.761) for the
CVHS, 0.689 (0.650–0.727) for the MAP and 0.666 (0.628–0.704)
for the KP studies.
Comparison of quartiles on the ANU-ADRI
To enable comparison of predictive validity between studies, the
incidence rates of AD (per 1000 person-years) were calculated by
quartile (Table 4). The incidence rate was significantly increased
with the increase of ANU-ADRI score in each quartile (p for linear
trend ,0?001) demonstrating a dose-response relationship be-
tween the ANU-ADRI and incident AD.
Comparison of adults aged ,70 with those $70 on the
ANU-ADRI
To evaluate the ANU-ADRI in adults aged younger than 70
years the CVHS sample was divided into two groups according to
age (,70 vs. $70 years) and the percentage of dementia cases per
quartile were compared. Table 5 shows that among younger
participants, the rates of dementia within the same quartile of risk
were the same except for Quartile 3 where they were significantly
lower.
C-statistics for the CAIDE Dementia Risk Score
To enable comparison of the ANU-ADRI with another
published risk score we applied the dementia risk score developed
from CAIDE study to the MAP, KP and CVHS cohorts. Table 6
shows the c-statistics for the CAIDE index for each study using
available risk factors, and also excluding cholesterol, and excluding
cholesterol and BMI. The c-statistics were higher excluding
cholesterol and BMI, and ranged from 0.552 to 0.584 for AD, and
from 0.549 to 0.595 for dementia.
Discussion
We report the first evaluation of an evidence-based AD Risk
Index exclusively based on self-reported information. The
approach used for the development of the ANU-ADRI overcomes
much of the sample bias that occurs when a measure is based on
data from a single study both at the development and at the
validation stage. When the c-statistic is estimated on the study
from which an instrument is developed, it is often optimized to the
characteristics of a specific study by trialling different cut-offs on
predictor variables to obtain the best score. This applies generally
to research in the development of risk assessment tools in medicine
and health, and not just to dementia. Our findings demonstrate
the value of evaluating different risk assessment tools on the same
cohorts in order to evaluate their potential validity in different
contexts. The c-statistics for this validation study compare
favourably with those of widely used instruments in other fields
of medicine even where they have been optimized to a single
study. The Framingham risk index had a c-statistic of 0?79 [20]
and one of the most commonly used breast cancer risk assessment
indices reported a c-statistic of 0?58 [21]. It is also noteworthy that
these and all dementia risk indices include age.
The ANU-ADRI includes 11 risk factors and four protective
factors, yet the evaluation samples included a maximum of only
eight to ten of these. This is in part due to the older age of the
cohorts which means that BMI and cholesterol could not be
included as predictors because the evidence for these relates only
to midlife. Despite this potential limitation, adequate results of c-
statistics ranging from 0.64 to 0.74 were obtained. Findings from
the present study may underestimate the sensitivity of this tool in
identifying individuals at increased risk of dementia when used in
younger cohorts or cohorts where more risk and protective factors
have been measured. The KP cohort included participants born
before 1912 and was older than the other two validation samples,
which is the likely explanation for the lower predictive validity of
the ANU-ADRI within this cohort. Although individuals with
baseline dementia were excluded from the KP study, it is possible
that the sample included participants with Mild Cognitive
Impairment (MCI) which again would reduce the sensitivity of
the analyses.
When a common set of risk and protective factors were used to
estimate the ANU-ADRI accuracy across cohorts there were
variations in the c-statistics. The largest decrement was seen in
MAP, and was explained by removal of the protective effect of
cognitively stimulating activities which was unique to MAP. In
contrast, there was very little change in the c-statistics for CVHS
after removing fish intake, and depression suggesting effects of
these factors are explained by other measures in the index.
Another dementia risk index for late-life was developed from the
CVHS dataset and included clinical, performance and lifestyle
data (n = 3608, mean baseline age 76 years) [10]. When evaluated
ANU-ADRI Validation
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Table 2. Descriptive statistics for the three evaluation cohorts, their measured risk and protective factors, and the points allocated
to each factor on the ANU-ADRI.
MAP (n=1164) KP (n =1301) CVHS (n=3375) Points
Location of study population United States Sweden United States
Age at baseline (years), mean (SD) 79?8 (7?4) 81?5 (5?0) 72?3 (4?9)
Range of age (years) 54–100 74–100 62–95
Gender: Male, n (%) 300 (24?8) 325 (25?0) 1381 (40.9)
Age for males (years), n (%) ,65 6 (0.5) 0 30 (0.9) 0
65–69 12 (1) 0 356 (10.5) 1
70–74 39 (3.4) 6 (0.5) 607 (18.0) 12
75–79 69 (5.9) 141 (10.8) 263 (7.8) 18
80–84 104 (8.9) 106 (8.1) 86 (2.5) 26
85–89 53 (4.6) 50 (3.8) 24 (0.7) 33
$90 17 (1.5) 22 (1.7) 3 (0.1) 38
Age for females (years), n (%) ,65 40 (3.4) 0 62 (1.8) 0
65–69 73 (6?3) 0 626 (18?5) 5
70–74 98 (8?4) 15 (1?2) 787 (23?3) 14
75–79 199 (17?1) 376 (28?9) 355 (10?5) 21
80–84 24?7 (21?2) 306 (23?5) 123 (3?6) 29
85–89 149 (12?8) 194 (14?9) 18 (0?5) 35
$90 57 (4?9) 85 (6?5) 1 (0) 41
Educational level (years), n (%) ,8 42 (3?5) 654 (50?3) 367 (11?0) 0
8–11 60 (5?0) 253 (19?4) 439 (13?1) 3
.11 1061 (87?8) 389 (29?9) 2537 (75?9) 6
Diabetes, n (%) No 1016 (94?4) 1187 (91?2) 2805 (83?1) 0
Yes 147 (12?2) 114 (8?5) 537 (16?0) 3
Traumatic Brain Injury, n (%) No 1098 (94?4) 877 (67?4) NA 0
Yes 65 (5?4) 86 (6?6) NA 4
Depressive symptoms, n (%) No NA NA 2811 (83?3) 0
Yes NA NA 180 (5?3) 2
Cognitively stimulating
activities, n (%)
Low 408 (33?8) NA NA 0
Moderate 600 (49?7) NA NA 26
High 155 (12?8) NA NA 27
Social network, n (%) High 97 (8?0) 13 (1?0) NA 0
Medium-high 328 (27?2) 226 (17?4) NA 1
Medium-low 422 (34?9) 880 (67?6) NA 4
Low 125 (10?3) 84 (6?5) NA 6
Smoking, n (%) Never smoked 685 (56?7) 867 (66?7) 1558 (46.5) 0
Former smoker 432 (35?8) NA 1426 (42.6) 1
Current smoker 44 (3?6) 104 (8?0) 364 (10.9) 4
Alcohol consumption, n (%) Abstainers 193 (16?0) 391 (30?1) 1585 (47?3) 0
Light-to-moderate 887 (74?3) 577 (44?4) 1634 (48?8) 23
Heavy 80 (6?6) 0 129 (3?9)
Physical activity, n (%) Low 465 (38?5) NA 993 (29?7) 0
Medium 495 (41?0) NA 1677 (50?2) 22
High 203 (16?8) NA 671 (20?1) 23
Fish intake (serves/week), n (%) 0–0?25 NA NA 388 (13?2) 0
0?26–2?0 NA NA 1168 (39?8) 23
2?1–4?0 NA NA 1263 (43?0) 24
$4?1 NA NA 119 (4?1) 25
Note. NA=Data not available either because it was not collected or collected but not in a format compatible with the ANU-ADRI. The points are the weights given to
each level of each variable in the ANU-ADRI risk score.
doi:10.1371/journal.pone.0086141.t002
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on the same dataset it had a c-statistic of 0?82 and a short form of
this risk assessment evaluated on the same dataset had a c-statistic
of 0.77 [19]. Age, poor cognitive performance, low BMI, APOE
genotype, white matter hyperintensities on brain MRI, ventricular
enlargement, thickening of the carotid artery, history of bypass
surgery, slow physical performance and abstaining from alcohol
were included in this risk index. It is likely that several of the risk
factors included in this index are not independent of AD, as
neurological changes such as ventricular enlargement, and poor
cognitive performance may be a consequence of the disease and be
evident prior to clinical diagnosis. Hence, this index is not directly
comparable with the ANU-ADRI or the CAIDE index. Integrat-
ing instrumental or laboratory assessments like MRI data, APOE
genotype, history of coronary artery disease, and diagnostic
assessments such as cognitive tests, would almost certainly increase
the predictive power of a risk index for AD. This may be desirable
in clinical settings. However, the purpose of the present study was
to develop an index for use in the population who are
asymptomatic to enable population level prevention strategies
and interventions.
The dementia risk index developed for the CAIDE study
includes age, sex, education, hypertension, high cholesterol and
obesity and predicted dementia risk over a 20 year follow-up
period [5] with a c-statistic of 0?77 on the study from which it was
developed. The CAIDE was developed using data on risk factors
in midlife and there is no comparable measure that has been
developed on risk factors measured in older adults. We evaluated
the CAIDE as a comparison measure for the ANU-ADRI because
Table 3. Characteristics and accuracy of ANU-ADRI for predicting AD and dementia in the three cohort studies.
MAP (n=903) KP (n=905) CVHS (n=2496)
Follow-up (years) Mean 3.5 (SD 3.0) Mean 6.0 (SD 5.7) Median 6.0
Risk and protective factors (10) Age, Gender, Education,
Diabetes, TBI, Cognitive Stimulating
Activities, Social Engagement,
Smoking, Alcohol, Physical Activity
(8) Age, Gender, Education,
Diabetes, TBI, Social Engagement,
Smoking, Alcohol
(9) Age, Gender, Education, Diabetes,
Depression, Smoking, Alcohol, Physical
Activity, Fish Intake
ANU-ADRI score
Mean (SD) 20?3 (11?78) 32.38 (7?67) 8.86 (8.77)
Quartiles, median (range)
Quartile 1 6?5 (211?0–13?0) 22?0 (13?0–27?0) 22.0 (210.0–3?0)
Quartile 2 18?0 (13?1–21?0) 30?0 (27?1–31?0) 6?0 (3.1–8?0)
Quartile 3 25?0 (21?1–29?0) 36?0 (31?1–37?0) 11?0 (8.1–14?5)
Quartile 4 34?0 (29?1–46?0) 42?0 (37?1–57?0) 19?0 (14.51–41?0)
Alzheimer’s Disease
AUC for men 0?715 (0?630–0?799) 0?672 (0?586–0?759) 0?732 (0?686–0?778)
AUC for female 0?744 (0?695–0?793) 0?620 (0?574–0?667) 0?742 (0?707–0?778)
AUC overall 0?733 (0?691–0?776) 0?637 (0?596–0?678) 0?740 (0?712–0?768)
AUC for common variables* 0.689 (0.650–0.727) 0.666 (0.628–0.704) 0.734 (0.707–0.761)
Any dementia
AUC for men 0?714 (0?630–0?797) 0?728 (0?655–0?801) 0?713 (0?670–0?756)
AUC for female 0?728 (0?679–0?778) 0?626 (0?582–0?670) 0?738(0?704–0?772)
AUC overall 0?721 (0?678–0?764) 0?653 (0?616–0?691) 0?728 (0?701–0?754)
AUC for common variables* 0.681 (0.644–0.719) 0.677 (0.642–0.711) 0.723 (0.698–0.749)
Note. The results for quartiles are the mean score within each quartile, the range of scores within each quartile of the observed ANU-ADRI scores within each cohort.
*Common variables for three studies included; age, sex, education, diabetes mellitus, smoking, and alcohol.
doi:10.1371/journal.pone.0086141.t003
Table 4. Incidence of AD (per 1000 person-years) and hazards ratios for AD by quartile of ANU-ADRI score.
ANU-ADRI score
(quartile) MAP (n=890) KP (n =904) CVHS (n=740)*
Incidence Hazard ratio (95% CI) Incidence Hazard ratio (95% CI) Incidence Hazard ratio (95% CI)
Quartile 1 12.79 Reference 13.88 Reference 30.16 Reference
Quartile 2 26.17 1.99 (0.92–4.28) 28.46 2.02 (1.24–3.30) 38.13 1.36 (0.84–2.18)
Quartile 3 63.51 4.92 (2.50–9.70) 53.70 3.61 (2.30–5.66) 56.39 2.13 (1.36–3.23)
Quartile 4 86.73 6.71 (3.45–13.06) 59.42 4.00 (2.51–6.31) 92.25 3.86 (2.55–5.90)
P for linear trend ,0.001 ,0.001 ,0.001
*There was a large amount of missing data for the CVHS on length of follow-up.
doi:10.1371/journal.pone.0086141.t004
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it included comparable risk factors. Moreover, it is valuable to
evaluate whether a risk index developed on midlife adults is
effective in predicting dementia when applied to older cohorts as
this would provide information about the need for development of
new indices such as the ANU-ADRI.
The analysis of CAIDE risk score showed that it did not have
high c-statistics when used on older cohorts, and suggests that its
use is likely to be optimal when applied to midlife cohorts. It is also
possible that the weights developed for CAIDE are study specific.
Our own analysis of the CVHS study comparing results for those
aged under 70 by quartile of ANU-ADRI score, with those aged
70 or over, showed general similarities in the proportions of
dementia cases in each age-group (Table 5). Nevertheless, due to
the diversity of risk factors and their own developmental
trajectories, there is a need for development of alternative
instruments that are applicable at different ages, or for instruments
that incorporate the flexibility to moderate risk scores based on
age.
From an epidemiological perspective, each cohort study may be
considered as an individual observation within the population of
cohort studies, and the best estimates of weights for risk factors will
be derived from the population. The most relevant weights are
therefore derived from meta-analyses of findings from cohort
studies reporting associations between risk factors and dementia.
To date there remain risk factors where there are insufficient
published studies to derive reliable estimates, and it is also possible
that estimates vary according to age but that this information is not
captured in publications which report a single risk estimate. Hence
it is likely that considerable refinement of the ANU-ADRI is
possible.
Limitations of the present study were that the evaluation
samples were relatively old at their baseline assessment and would
have been affected by selection bias in their initial recruitment.
Hence the validity and ultimate utility of the ANU-ADRI needs to
be further evaluated on younger cohorts. This will be done as
datasets become available. The need to exclude those with
prevalent dementia at baseline for this validation exercise also may
result in a selected sample which would represent lower rates of
dementia than those found in the population. We expect the c-
statistics to be higher when risk factors are assessed in middle age
[19]. The older ages of the validation samples precluded inclusion
of risk factors such as high cholesterol and overweight or obese
BMI, which are risk factors for dementia only when measured at
middle age. The length of follow-up of the evaluation studies was
relatively short, given that a number of risk factors included in the
ANU-ADRI have been shown to be predictive from midlife in
individual cohort studies [2]. Isolated findings from the KP, MAP
and CVHS cohorts were also included in some of the meta-
analyses that were used to derive effect sizes for the ANU-ADRI
hence the validation samples were not purely independent of the
measure development. For example, the KP contributed data to
the pooled effect size for social networks. Most of the studies
included in meta-analyses of risk factors for dementia control for
covariates e.g. [22] yet there remains a possibility that the risk
scores are influenced by residual confounding. This limitation
would apply to other risk indices in the literature. The lack of
biomarkers of AD and cerebrovascular disease in the cohorts
examined means that it is likely that the extent of cerebrovascular
disease and premorbid AD in the cohorts were underestimated.
The close correspondence between the AUCs for dementia and
AD suggests that the measure applies more broadly to dementia
risk although the measure was based entirely on effect sizes derived
from studies of AD.




score range Age range 65–69 Age range 70–95 x2, p-value
n Dementia cases % n Dementia Cases %
Quartile 1 210 to 3 649 114 18 100 22 22 1.817, ns
Quartile 2 3.01 to 8 328 65 20 344 93 27 0.350, ns
Quartile 3 8.01 to 14.5 186 47 25 523 163 31 13.350, p,0.001
Quartile 4 14.51 to 42 44 16 36 517 220 43 0.178, ns
doi:10.1371/journal.pone.0086141.t005
Table 6. Characteristics and accuracy of CAIDE for predicting AD and dementia in the three cohort studies.
MAP (n=903) KP (n=905) CVHS (n=2496)
Alzheimer’s Disease
AUC overall 0?491 (0?427–0?554) 0?533 (0?487–0?580) 0?568 (0?536–0?600)
AUC excluding BMI 0?543(0?482–0?605) 0?529 (0?485–0?573) 0?584 (0?552–0?610)
AUC excluding BMI & cholesterol 0?552 (0?509–0?594) N/A* 0?584 (0?552–0?616)
Any dementia
AUC overall 0?488 (0?426–0?549) 0?538 (0?496–0?579) 0?570 (0?541–0?600)
AUC excluding BMI 0.540 (0.480–0.599) 0?536 (0.497–0.574) 0?589(0?560–0?619)
AUC excluding BMI & cholesterol 0?549 (0?507–0?591) N/A* 0?595 (0?565–0?625)
*cholesterol data were unavailable for the KP study.
doi:10.1371/journal.pone.0086141.t006
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The ANU-ADRI is based on the current knowledge of risk
factors for AD. For example, in systematic reviews, hypertension
has not been shown to be an independent risk factor for AD [23]
yet it is possible that this is due to methodological factors
influencing the measurement of hypertension in cohort studies.
Hence limitations in the current knowledge base on risk factors for
AD will also be limitations of the ANU-ADRI and any similar risk
index.
Strengths of this study included the validation of the ANU-
ADRI on cohorts from varied geographical locations with different
population characteristics, supporting the generalizability of the
instrument. The ANU-ADRI can be delivered via the internet,
providing a virtually free method of risk assessment that may be
used in universal population-health initiatives and by clinicians.
The ANU-ADRI represents an advance in assessing risk profiles
for dementia by including a wider range of factors than previous
measures, and drawing on a wider range of literature in its
development and evaluation. The methodology used to develop
the ANU-ADRI enables it to be updated and improved as new
information becomes available. For example, there is increasing
evidence that exposure to air pollution increases the risk of
cognitive decline [24] and possibly dementia. Future research
evaluating the ANU-ADRI scores against biomarkers will enable
refinement of the measure and clarification of the extent to which
it measures AD risk specifically, compared to all cause dementia.
Finally, the ANU-ADRI is available at http://anuadri.anu.edu.au
for use by individuals and researchers.
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